SCHEMBL13487293

SCHEMBL13487293

CC1(C)c2ccccc2-c2c(-c3c4ccccc4c(-c4cc(-c5ccccc5)c5ccccc5n4)c4ccc(-c5ccc6ccccc6c5)cc34)cccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACA Q13085 6/20 0.41
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 3/20 0.33
HPGD P15428 3/20 0.33
MAPT P10636 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
MAPK1 P28482 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
NPSR1 Q6W5P4 2/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33
NFKB1 P19838 1/20 0.33
RAB9A P51151 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
ATM Q13315 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
DHODH Q02127 3/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13487115 0.94 ACACA (0.42) ACACAKDM4EALDH1A1HPGDMAPT
SCHEMBL13487372 0.92 ACACA (0.40) ACACAKDM4EALDH1A1HPGDMAPT
SCHEMBL13487183 0.91 ACACA (0.40) ACACAKDM4EALDH1A1HPGDMAPT
SCHEMBL13487272 0.90 NPC1 (0.36) ACACAKDM4EALDH1A1HPGDMAPT
SCHEMBL13488060 0.89 ACACA (0.42) ACACAKDM4EALDH1A1HPGDMAPT
SCHEMBL13487294 0.89 ESR1 (0.36) ACACAKDM4EALDH1A1HPGDMAPT
SCHEMBL13487318 0.88 CYP1A1 (0.38) ACACAKDM4EALDH1A1HPGDMAPT
SCHEMBL13487669 0.88 ACACA (0.41) ACACAKDM4EALDH1A1HPGDMAPT
SCHEMBL13487105 0.88 NPC1 (0.36) ACACAKDM4EALDH1A1HPGDMAPT
SCHEMBL13487287 0.87 MET (0.36) KDM4EALDH1A1HPGDMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
EP-2108689-A2 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-10-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 ACACA 1675/4885KDM4E 3671/4885ALDH1A1 101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.